AstraZeneca PLC
11594.00
20-二月-25 11:29:46
15 分钟延时
股票
-96.00
-0.82%
今日范围
11444.00 - 11610.00
ISIN
N/A
来源
Cboe
-
NetDania - New 12 months High: AstraZeneca PLC
30 8月 2024 06:41:41 条件 NetDania Notify
-
Interesting AZN Put And Call Options For November 15th
23 8月 2024 11:14:24 条件 NASDAQ Stocks
-
AZN: Enhertu Gets US Breakthrough Therapy Designation For HER2 Low/Ultralow Metastatic Breast Cancer
19 8月 2024 03:08:28 条件 NASDAQ US Markets
-
AstraZeneca's Imfinzi Gets US Approval For Resectable Early-stage Lung Cancer
16 8月 2024 03:28:46 条件 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
16 8月 2024 03:17:04 条件 NetDania Notify
-
AstraZeneca (AZN) Imfinzi Combo Gets EU Nod for Uterine Cancer
15 8月 2024 07:38:12 条件 NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
15 8月 2024 03:15:16 条件 NetDania Notify
-
NetDania - New 12 months High: AstraZeneca PLC
13 8月 2024 03:19:30 条件 NetDania Notify
-
Ex-Dividend Reminder: Cencora, AstraZeneca and Wells Fargo
07 8月 2024 10:27:01 条件 NASDAQ Stocks
-
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
04 8月 2024 10:42:17 条件 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
29 7月 2024 08:07:19 条件 NetDania Notify
-
AstraZeneca: Calquence Combo Enhances PFS In First-Line CLL In Phase III Trial
29 7月 2024 03:38:02 条件 NASDAQ US Markets
-
AstraZeneca Reports ODAC's Review Of Imfinzi - Quick Facts
26 7月 2024 03:05:05 条件 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
25 7月 2024 03:15:03 条件 NetDania Notify
-
AstraZeneca Q2 Profit Rises, Lifts FY24 Outlook
25 7月 2024 02:51:34 条件 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
23 7月 2024 06:15:26 条件 NetDania Notify
-
NetDania - New 12 months High: AstraZeneca PLC
22 7月 2024 08:17:57 条件 NetDania Notify
-
Interesting AZN Put And Call Options For August 23rd
03 7月 2024 13:16:51 条件 NASDAQ US Markets
-
AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer
01 7月 2024 03:09:21 条件 NASDAQ US Markets
-
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
28 6月 2024 10:33:02 条件 NASDAQ Stocks